Abstract
Stratification of treatment decision making and execution for patients with surgical neck endocrine disorders will involve both patient related elements and health care environmental conditions related to the pandemic involving: Disease entity, health care resources, facility capability and availability of viral testing.
Highlights
The onset and rapid progression of the novel coronavirus, SARS-CoV-2, pandemic has created a widely variable viewpoint in decision making and execution in a variety of surgical disorders
Otolaryngologists/head and neck surgeons are at the highest risk of exposure and potential for infection, owing to the fact that the greatest viral density is found in the nasal cavity/nasopharynx, and manipulation of these anatomic areas thru diagnostic and therapeutic procedures carries with it possible aerosolization of viral particles within droplets during upper aerodigestive tract (UADT) procedures/surgery [2]
Apart from procedures involving the UADT, other neck procedures which do not directly involve high risk anatomic areas, may involve, directly or indirectly, portions of the aerodigestive system, and raise the risk of exposure. We offer in this presentation, recommendations for decision making and surgical management of neck endocrine disorders during the viral pandemic, relative to: Specific disorders and the urgency for surgery, alternative non-surgical management, risk assessment with respect to viral exposure, and technical surgical nuances
Summary
Neck Endocrine Surgery in the Era of COVID-19 Surgical Decision Making and Operative Execution.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
